Genetic and Cellular Basics of H. pylori pathogenesis
幽门螺杆菌发病机制的遗传和细胞基础知识
基本信息
- 批准号:7365261
- 负责人:
- 金额:$ 39.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-05-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdhesionsAnimal ModelAnimalsApicalBacteriaBacterial Attachment SiteBacterial ChromosomesBacterial PhysiologyBasement membraneBehaviorBiochemicalBiologicalCancer BiologyCell AdhesionCell CommunicationCell PolarityCell membraneCell surfaceCell-Cell AdhesionCellsCellular MorphologyCellular biologyChronicClassClinicalComplexConfocal MicroscopyCultured CellsCytosolDefectDifferentiation and GrowthDiseaseDockingEnvironmentEpithelialEpithelial CellsEpitheliumFractionationGastric AdenocarcinomaGastric lymphomaGastric mucosaGastritisGenesGeneticGreen Fluorescent ProteinsGrowth Factor ReceptorsHalf-LifeHealedHelicobacter InfectionsHelicobacter pyloriHumanIn VitroInfectionIntegral Membrane ProteinInvasiveLaboratoriesLasersLeadLengthLifeLinkLocalizedMalignant NeoplasmsMembrane ProteinsMesenchymalMetalloproteasesMethodsMicrobeMicrodissectionMicroscopicMicroscopyModelingMolecularMovementMucous MembraneMusN-terminalNumbersNutrientPTPN11 genePathogenesisPathogenicity IslandPathway interactionsPeptic UlcerPhysiologicalPhysiologyPopulationProcessProtein Tyrosine PhosphataseProteinsPseudopodiaPurposeReceptor Protein-Tyrosine KinasesReceptor SignalingRecruitment ActivityReporterResearchResearch PersonnelRiskRoleSamplingScaffolding ProteinSignal PathwaySignal TransductionSiteStomachStomach DiseasesStructureSurfaceSwimmingSyringesSystemTestingTight JunctionsTissuesTransfectionTyrosineUlcerVirulenceWeekWorkWound Healingbasecell motilitydayenteropathogenic Escherichia colihealingin vivoiodixanoljunctional adhesion moleculemalignant stomach neoplasmmicrobialmicroorganismmonolayermouse modelmutantnovelpolarized cellprogramspromoterreceptorresearch studytissue culturetool
项目摘要
H. pylori is a remarkable microorganism that is uniquely adapted for survival in the human stomach,
t infects, usually asymptomatically, over one half of the world's human population. However 15% of
those infected will develop ulcer disease or gastric cancer. Our proposed research focuses on a single
bacterial determinant, CagA, an effector protein translocated by a bacterial secretory apparatus into
gastric epithelial cells. CagA is arguably the most important virulence determinant of this microbe, since
ts presence is clearly correlated with ulcer disease and gastric malignancy, and its effects on host cell
biology place it at the crux between microbial pathogenesis and cancer biology. We propose to address
three fundamental questions related to how the initial encounter between the H. pylori CagA protein
works to the advantage of the microorganism and to the detriment of the host. First, what are the
molecular mechanisms by which CagA perturbs host epithelial cell biology? Second, what is the role of
CagA for H. pylori survival in close association with the host cell surface? And finally, what are the in-
vivo consequences of CagA delivery to the gastric mucosa in an animal model? Our previous research
directs us to a clear focus on the interaction of the CagA protein and the host proteins of the apical
junctional complex, a domain of the cell that controls cell polarity, provides the barrier function of the
mucosa, and regulates the differentiation, growth and wound healing capacities of epithelia. CagA also
triggers one, or possibly more, receptor tyrosine kinase signaling pathways. We predict that these are
not unrelated functions, but rather that CagA usurps an intrinsic link between growth factor receptor
signaling and the apical junctions. We have also hypothesized that H. pylori utilizes CagA to modify the
host cell surface for colonization purposes, recruiting specific host proteins to the sites of bacterial
attachment, disrupting cell polarity, and opening the epithelial junctions. We have proposed a
hypothesis of CagA action that we believe can be tested both in-vitro and in-vivo. We have developed
novel microscopic tools and an experimentally tractable model of chronic infection of polarized cells in
culture to examine the cell biology of the CagA-host cell interaction. Moreover, we will also make
extensive use of direct biochemical fractionation and transcriptional analysis to dissect the role of CagA
at a molecular level. Finally we propose testing the observations we have gathered from precise in-vitro
analysis in the more complex, but more relevant environment of the stomach in an animal host.
H.幽门螺杆菌是一种独特地适合于在人胃中存活的显著微生物,
t感染,通常无症状,超过一半的世界人口。然而,15%的
受感染者会患上溃疡病或胃癌。我们的研究重点是一个单一的
细菌决定簇,CagA,一种由细菌分泌器转运到
胃上皮细胞CagA可以说是这种微生物最重要的毒力决定因素,因为
ts存在与溃疡病和胃恶性肿瘤明显相关,其对宿主细胞的影响
生物学将其置于微生物发病机制和癌症生物学之间的关键位置。我们建议解决
三个基本问题涉及到如何在H.幽门螺杆菌CagA蛋白
对微生物有利而对宿主有害。首先,
CagA干扰宿主上皮细胞生物学的分子机制?第二,什么是角色
CagA for H.幽门螺杆菌的生存与宿主细胞表面密切相关?最后,什么是在-
在动物模型中CagA递送到胃粘膜的体内后果?我们之前的研究
引导我们明确关注CagA蛋白和顶端的宿主蛋白的相互作用,
连接复合物是控制细胞极性的细胞结构域,提供细胞膜的屏障功能。
粘膜,并调节上皮细胞的分化、生长和伤口愈合能力。CagA也
触发一个或可能多个受体酪氨酸激酶信号通路。我们预测,
不是无关的功能,而是CagA篡夺了生长因子受体之间的内在联系,
信号传导和顶端连接。我们还假设H. pylori利用CagA修饰
宿主细胞表面用于定殖目的,将特定的宿主蛋白质募集到细菌的位点,
附着,破坏细胞极性,并打开上皮连接。我们提出了一种
CagA作用的假说,我们相信可以在体外和体内进行测试。我们已经开发
新的显微工具和实验上易于处理的极化细胞慢性感染模型,
培养以检查CagA与宿主细胞相互作用的细胞生物学。此外,我们还将使
广泛使用直接生化分离和转录分析来剖析CagA的作用
在分子水平上。最后,我们建议测试我们从精确的体外实验中收集到的观察结果。
在更复杂但更相关的动物宿主胃环境中进行分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LUCY Stuart TOMPKINS其他文献
LUCY Stuart TOMPKINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LUCY Stuart TOMPKINS', 18)}}的其他基金
Epidemiology of Emerging Infectious Diseases and Bioterr
新发传染病的流行病学和 Bioterr
- 批准号:
6777577 - 财政年份:2003
- 资助金额:
$ 39.38万 - 项目类别:
Epidemiology of Emerging Infectious Diseases and Bioterr
新发传染病的流行病学和 Bioterr
- 批准号:
7264585 - 财政年份:2003
- 资助金额:
$ 39.38万 - 项目类别:
Epidemiology of Emerging Infectious Diseases and Bioterr
新发传染病的流行病学和 Bioterr
- 批准号:
7111668 - 财政年份:2003
- 资助金额:
$ 39.38万 - 项目类别:
Epidemiology of Emerging Infectious Diseases and Bioterr
新发传染病的流行病学和 Bioterr
- 批准号:
6657862 - 财政年份:2003
- 资助金额:
$ 39.38万 - 项目类别:
Epidemiology of Emerging Infectious Diseases and Bioterr
新发传染病的流行病学和 Bioterr
- 批准号:
6892165 - 财政年份:2003
- 资助金额:
$ 39.38万 - 项目类别:
GENETIC AND CELLULAR BASIS OF H. PYLORI PATHOGENESIS
幽门螺杆菌发病的遗传和细胞基础
- 批准号:
6631807 - 财政年份:1996
- 资助金额:
$ 39.38万 - 项目类别:
Genetic and Cellular Basics of H. pylori pathogenesis
幽门螺杆菌发病机制的遗传和细胞基础知识
- 批准号:
7031510 - 财政年份:1996
- 资助金额:
$ 39.38万 - 项目类别:
Genetic and Cellular Basics of H. pylori pathogenesis
幽门螺杆菌发病机制的遗传和细胞基础知识
- 批准号:
7176212 - 财政年份:1996
- 资助金额:
$ 39.38万 - 项目类别:
Genetic and Cellular Basics of H. pylori pathogenesis
幽门螺杆菌发病机制的遗传和细胞基础知识
- 批准号:
7574591 - 财政年份:1996
- 资助金额:
$ 39.38万 - 项目类别:
GENETICS AND CELLULAR BASIS OF H PYLORI PATHOGENESIS
幽门螺杆菌发病的遗传学和细胞基础
- 批准号:
2887063 - 财政年份:1996
- 资助金额:
$ 39.38万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 39.38万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 39.38万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 39.38万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 39.38万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 39.38万 - 项目类别: